BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 28207798)

  • 41. Sake lees extract improves hepatic lipid accumulation in high fat diet-fed mice.
    Kubo H; Hoshi M; Matsumoto T; Irie M; Oura S; Tsutsumi H; Hata Y; Yamamoto Y; Saito K
    Lipids Health Dis; 2017 Jun; 16(1):106. PubMed ID: 28578672
    [TBL] [Abstract][Full Text] [Related]  

  • 42. (S)YS-51, a novel isoquinoline alkaloid, attenuates obesity-associated non-alcoholic fatty liver disease in mice by suppressing lipogenesis, inflammation and coagulation.
    Park EJ; Kim YM; Kim HJ; Jang SY; Oh MH; Lee DH; Chang KC
    Eur J Pharmacol; 2016 Oct; 788():200-209. PubMed ID: 27343380
    [TBL] [Abstract][Full Text] [Related]  

  • 43. 14-3-3β and γ differentially regulate peroxisome proliferator activated receptor γ2 transactivation and hepatic lipid metabolism.
    Park S; Yoo S; Kim J; An HT; Kang M; Ko J
    Biochim Biophys Acta; 2015 Oct; 1849(10):1237-47. PubMed ID: 26260846
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Protein kinase STK25 regulates hepatic lipid partitioning and progression of liver steatosis and NASH.
    Amrutkar M; Cansby E; Nuñez-Durán E; Pirazzi C; Ståhlman M; Stenfeldt E; Smith U; Borén J; Mahlapuu M
    FASEB J; 2015 Apr; 29(4):1564-76. PubMed ID: 25609431
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Low-Density Lipoprotein Receptor-Related Protein-1 Protects Against Hepatic Insulin Resistance and Hepatic Steatosis.
    Ding Y; Xian X; Holland WL; Tsai S; Herz J
    EBioMedicine; 2016 May; 7():135-45. PubMed ID: 27322467
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mindin/Spondin 2 inhibits hepatic steatosis, insulin resistance, and obesity via interaction with peroxisome proliferator-activated receptor α in mice.
    Zhu LH; Wang A; Luo P; Wang X; Jiang DS; Deng W; Zhang X; Wang T; Liu Y; Gao L; Zhang S; Zhang X; Zhang J; Li H
    J Hepatol; 2014 May; 60(5):1046-54. PubMed ID: 24445216
    [TBL] [Abstract][Full Text] [Related]  

  • 47. MiR-22 modulates the expression of lipogenesis-related genes and promotes hepatic steatosis in vitro.
    Yang Z; Qin W; Huo J; Zhuo Q; Wang J; Wang L
    FEBS Open Bio; 2021 Jan; 11(1):322-332. PubMed ID: 33159388
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ablation of prolactin receptor increases hepatic triglyceride accumulation.
    Shao S; Yao Z; Lu J; Song Y; He Z; Yu C; Zhou X; Zhao L; Zhao J; Gao L
    Biochem Biophys Res Commun; 2018 Apr; 498(3):693-699. PubMed ID: 29524401
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Deficiency of eNOS exacerbates early-stage NAFLD pathogenesis by changing the fat distribution.
    Nozaki Y; Fujita K; Wada K; Yoneda M; Shinohara Y; Imajo K; Ogawa Y; Kessoku T; Nakamuta M; Saito S; Masaki N; Nagashima Y; Terauchi Y; Nakajima A
    BMC Gastroenterol; 2015 Dec; 15():177. PubMed ID: 26678309
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Benzbromarone aggravates hepatic steatosis in obese individuals.
    Sun P; Zhu JJ; Wang T; Huang Q; Zhou YR; Yu BW; Jiang HL; Wang HY
    Biochim Biophys Acta Mol Basis Dis; 2018 Jun; 1864(6 Pt A):2067-2077. PubMed ID: 29526820
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Genipin alleviates high-fat diet-induced hyperlipidemia and hepatic lipid accumulation in mice via miR-142a-5p/SREBP-1c axis.
    Zhong H; Chen K; Feng M; Shao W; Wu J; Chen K; Liang T; Liu C
    FEBS J; 2018 Feb; 285(3):501-517. PubMed ID: 29197188
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Euterpe oleracea Mart.-Derived Polyphenols Protect Mice from Diet-Induced Obesity and Fatty Liver by Regulating Hepatic Lipogenesis and Cholesterol Excretion.
    de Oliveira PR; da Costa CA; de Bem GF; Cordeiro VS; Santos IB; de Carvalho LC; da Conceição EP; Lisboa PC; Ognibene DT; Sousa PJ; Martins GR; da Silva AJ; de Moura RS; Resende AC
    PLoS One; 2015; 10(12):e0143721. PubMed ID: 26630290
    [TBL] [Abstract][Full Text] [Related]  

  • 53. INT-767 improves histopathological features in a diet-induced
    Roth JD; Feigh M; Veidal SS; Fensholdt LK; Rigbolt KT; Hansen HH; Chen LC; Petitjean M; Friley W; Vrang N; Jelsing J; Young M
    World J Gastroenterol; 2018 Jan; 24(2):195-210. PubMed ID: 29375205
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Fish oil alleviated high-fat diet-induced non-alcoholic fatty liver disease via regulating hepatic lipids metabolism and metaflammation: a transcriptomic study.
    Yuan F; Wang H; Tian Y; Li Q; He L; Li N; Liu Z
    Lipids Health Dis; 2016 Feb; 15():20. PubMed ID: 26832365
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Thyrotropin increases hepatic triglyceride content through upregulation of SREBP-1c activity.
    Yan F; Wang Q; Lu M; Chen W; Song Y; Jing F; Guan Y; Wang L; Lin Y; Bo T; Zhang J; Wang T; Xin W; Yu C; Guan Q; Zhou X; Gao L; Xu C; Zhao J
    J Hepatol; 2014 Dec; 61(6):1358-64. PubMed ID: 25016220
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Deletion of exons 3 and 4 in the mouse Nr1d1 gene worsens high-fat diet-induced hepatic steatosis.
    Na H; Lee H; Lee MH; Lim HJ; Kim HJ; Jeon Y; Kang HL; Lee MO
    Life Sci; 2016 Dec; 166():13-19. PubMed ID: 27720799
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Adzuki bean ameliorates hepatic lipogenesis and proinflammatory mediator expression in mice fed a high-cholesterol and high-fat diet to induce nonalcoholic fatty liver disease.
    Kim S; Hong J; Jeon R; Kim HS
    Nutr Res; 2016 Jan; 36(1):90-100. PubMed ID: 26773785
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Non-alcoholic fatty liver disease induces signs of Alzheimer's disease (AD) in wild-type mice and accelerates pathological signs of AD in an AD model.
    Kim DG; Krenz A; Toussaint LE; Maurer KJ; Robinson SA; Yan A; Torres L; Bynoe MS
    J Neuroinflammation; 2016 Jan; 13():1. PubMed ID: 26728181
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Intestinal farnesoid X receptor signaling promotes nonalcoholic fatty liver disease.
    Jiang C; Xie C; Li F; Zhang L; Nichols RG; Krausz KW; Cai J; Qi Y; Fang ZZ; Takahashi S; Tanaka N; Desai D; Amin SG; Albert I; Patterson AD; Gonzalez FJ
    J Clin Invest; 2015 Jan; 125(1):386-402. PubMed ID: 25500885
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Dietary modification dampens liver inflammation and fibrosis in obesity-related fatty liver disease.
    Larter CZ; Yeh MM; Haigh WG; Van Rooyen DM; Brooling J; Heydet D; Nolan CJ; Teoh NC; Farrell GC
    Obesity (Silver Spring); 2013 Jun; 21(6):1189-99. PubMed ID: 23666886
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.